Amarin (AMRN) Slips as FDA Updates Orange Book
Tweet
Share
E-mailGet Alerts AMRN Hot Sheet
Join SI Premium – FREE
Amarin Corp Plc (NASDAQ: AMRN) shares slump in afternoon trading Friday following the FDA updating its Orange Book.
To access the Vascepa page at the FDA, click here.
Shares are down 0.7 percent today.
To access the Vascepa page at the FDA, click here.
Shares are down 0.7 percent today.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Reddit (RDDT) added to S&P 500
- Quantum BioPharma gets FDA nod for Lucid-MS Phase 2 MS trial
- FDA approves Lantheus tau PET imaging agent for Alzheimer's disease
Create E-mail Alert Related Categories
FDA, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
